Gapping down
Other news: VLTC -22% (disclosed that the NASDAQ determined to delist its common stock effective December 23 at the open), SSI -4.1% (light volume, increases total capacity under its senior secured revolving credit facility from $350 million to $450 million), CLLS -3.0% (light volume; co to host call Dec 20 at 8:30 am ET to discuss the National Institutes of Health Recombinant DNA Advisory Committee meeting held on Dec 14), AZN -2.3% (Innate Pharma announced the appointment of Mondher Mahjoubi as Chairman of its Executive Board; Dr Mahjoubi, MD is currently Senior Vice President, Therapeutic Area Head-Oncology, Global Product and Portfolio Strategy, at AstraZeneca), FCX -1.7% (still checking for anything specific).
Analyst actions: MT -2.7% (downgraded to Sell from Neutral at UBS), DB -2.2% (downgraded to Sell from Neutral at Citigroup).
Analyst actions: MT -2.7% (downgraded to Sell from Neutral at UBS), DB -2.2% (downgraded to Sell from Neutral at Citigroup).